[Correlation between cognitive and motor functions in Parkinson's disease]
Hidetomo Murakami1, Mitsuru Kawamura
1Department of Neurology, School of Medicine, Showa University.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|February 14, 2014
Summary
Parkinson's disease patients experience cognitive and motor impairments. Anti-dementia drugs may treat both, suggesting shared pathophysiology between cognitive and motor functions.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Context:
- Parkinson's disease (PD) is characterized by early cognitive impairments alongside motor symptoms.
- Existing treatments for cognitive deficits include cholinesterase inhibitors and NMDA receptor antagonists.
- Clinical interest is growing in the correlation between cognitive and motor functions in PD.
Purpose:
- To explore the shared pathophysiology between cognitive and motor dysfunctions in Parkinson's disease.
- To investigate the potential of anti-dementia drugs in treating both cognitive and motor symptoms.
- To utilize medication outcomes as a tool for understanding PD pathophysiology.
Summary:
- Previous research linked executive/frontal dysfunction and motor symptoms to fronto-striatal circuit dysfunction.
- Recent findings correlate visuospatial/parietal dysfunction with motor symptoms, particularly postural instability, suggesting parietal lobe and basal ganglia connections.
- Anti-dementia drugs like donepezil and memantine may alleviate postural instability, potentially by targeting common pathophysiological pathways.
Impact:
- Findings suggest a potential for simultaneous treatment of cognitive and motor impairments in PD.
- Understanding shared pathophysiology can guide the development of novel therapeutic strategies.
- Medication-based analysis offers a pharmacological approach to elucidate complex disease mechanisms.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35